Simon Crerar

1 month ago | smartcompany.com.au | Eloise Keating |Simon Crerar

“Sometimes awards can just end up as an email stamp, but events like this are where the real value lies.” That’s how Tractor Ventures co-founder Jodie Imam described the recent Smart50 Winners Breakfast at The Langham in Melbourne. More than just a celebration of success, the event — hosted by SmartCompany and proudly supported by Optus — was designed to foster deeper connections, share insights, and strengthen the Smart50 alumni community.

1 month ago | smartcompany.com.au | Emma Koehn |Tegan Jones |Simon Crerar |Eloise Keating

In a buzzing conference hall in Las Vegas, Heidi Health is focused on a mission to dominate the increasingly crowded global market of AI health tools. The Australian-founded AI medical scribe business, which saves doctors’ time by transcribing and processing patient visits, revealed its first major international capital injection this week.

1 month ago | smartcompany.com.au | Tegan Jones |Simon Crerar |Michelle Gibbings |Dominic Price

More than 60% of people would rather see a colleague fired than working with someone they consider disorganised. This has come from a new study from Atlassian’s Teamwork Lab, which also found that 78% of people would rather take on extra work themselves than collaborate with someone they see as poorly organised. Dr Molly Sands, head of the Teamwork Lab, said while some individuals struggle with organisation, others may simply have personal systems that appear chaotic to their colleagues.

2 months ago | smartcompany.com.au | Tegan Jones |Simon Crerar |Penny Locaso |Dickie Currer

Melbourne-based enterprise technology startup Factor House has raised $5 million in seed funding to accelerate the launch of its flagship product, the Factor Platform. According to the business, the platform simplifies real-time data management for businesses of all sizes. The funding round was led by Blackbird Ventures, with participation from OIF Ventures, Flying Fox Ventures, and LaunchVic’s Alice Anderson Fund.

2 months ago | smartcompany.com.au | Jason Murphy |David Adams |Simon Crerar |Brianna Boecker

Novo Nordisk’s annual results are out and they show the Danish pharmaceutical juggernaut earnt 290.4 billion Danish kroner last year (AUD$64 billion) — up 25%. Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment. Never before was there a drug that actually worked for weight loss. Now there is. The Copenhagen-based company’s revenue was equal to 10% of Denmark’s GDP last year.